Marcus Pressler1, Peg Nopoulos, Beng-Choon Ho, Nancy C Andreasen. 1. Mental Health-Clinical Research Center, Department of Psychiatry, College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. marcus-pressler@uiowa.edu
Abstract
BACKGROUND: The insular cortex is a limbic integration region engaged in emotional and cognitive functions. Previously, we found that neuroleptic-naive subjects had abnormally small insular volumes compared with control subjects, with volume directly related to severity of psychotic symptoms. METHODS: To further investigate insular cortex abnormalities and their functional correlates, we measured insular gray matter volume and cortical surface size, using magnetic resonance images among 30 patients with schizophrenia and a matched control group. The sample was designed to represent a variety of phenomenologic profiles to provide sufficient variance in multiple measures, including severity of illness and exposure to neuroleptics (typical only). RESULTS: There were no significant differences in morphology between patients and control subjects; however, among patients, psychotic symptoms were inversely correlated with insular volume, replicating our previous finding in neuroleptic-naive subjects. Neuroleptic exposure had a specific effect on insular morphology: increasing drug exposure (measured in dose-years) correlated with larger insular volume. CONCLUSIONS: This effect of neuroleptic exposure might account for the lack of difference in structural measures in this more chronic sample, whereas the initial study on neuroleptic-naive subjects showed group differences. Further research is needed to investigate the potential relationship between changes in insula volume from neuroleptic exposure and clinical outcome.
BACKGROUND: The insular cortex is a limbic integration region engaged in emotional and cognitive functions. Previously, we found that neuroleptic-naive subjects had abnormally small insular volumes compared with control subjects, with volume directly related to severity of psychotic symptoms. METHODS: To further investigate insular cortex abnormalities and their functional correlates, we measured insular gray matter volume and cortical surface size, using magnetic resonance images among 30 patients with schizophrenia and a matched control group. The sample was designed to represent a variety of phenomenologic profiles to provide sufficient variance in multiple measures, including severity of illness and exposure to neuroleptics (typical only). RESULTS: There were no significant differences in morphology between patients and control subjects; however, among patients, psychotic symptoms were inversely correlated with insular volume, replicating our previous finding in neuroleptic-naive subjects. Neuroleptic exposure had a specific effect on insular morphology: increasing drug exposure (measured in dose-years) correlated with larger insular volume. CONCLUSIONS: This effect of neuroleptic exposure might account for the lack of difference in structural measures in this more chronic sample, whereas the initial study on neuroleptic-naive subjects showed group differences. Further research is needed to investigate the potential relationship between changes in insula volume from neuroleptic exposure and clinical outcome.
Authors: Babak A Ardekani; Arthika Bappal; Debra D'Angelo; Manzar Ashtari; Todd Lencz; Philip R Szeszko; Pamela D Butler; Daniel C Javitt; Kelvin O Lim; Jan Hrabe; Jay Nierenberg; Craig A Branch; Matthew J Hoptman Journal: Neuroreport Date: 2005-09-08 Impact factor: 1.837
Authors: Maria S M Wai; Chun Shi; W H Kwong; Lihong Zhang; Wai Ping Lam; David T Yew Journal: Histochem Cell Biol Date: 2008-09-02 Impact factor: 4.304
Authors: Vladimir V Senatorov; Ruslan Damadzic; Claire L Mann; Melanie L Schwandt; David T George; Daniel W Hommer; Markus Heilig; Reza Momenan Journal: Brain Date: 2014-11-02 Impact factor: 13.501
Authors: André Schmidt; Lena Palaniyappan; Renata Smieskova; Andor Simon; Anita Riecher-Rössler; Undine E Lang; Paolo Fusar-Poli; Philip McGuire; Stefan J Borgwardt Journal: J Psychiatry Neurosci Date: 2016-10 Impact factor: 6.186
Authors: Herbert Y Meltzer; Roger Mills; Stephen Revell; Hilde Williams; Ann Johnson; Daun Bahr; Joseph H Friedman Journal: Neuropsychopharmacology Date: 2009-11-11 Impact factor: 7.853
Authors: Michael T Compton; Sandra M Goulding; Claire E Ramsay; Jean Addington; Cheryl Corcoran; Elaine F Walker Journal: Clin Neuropsychiatry Date: 2008-12
Authors: Jeremy D Cohen; Taylor Nichols; Jennifer Keller; Rowena G Gomez; Alan F Schatzberg; Allan L Reiss Journal: Neurosci Res Date: 2013-03-05 Impact factor: 3.304